GGrantIndex
← Leaderboards

Mary Helen Barcellos-Hoff

University Of California, San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$12,888,180
Attributed
$15,043,915
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,043,915 · 11

By mechanism

R01$11,709,261 · 6
U54$1,851,193 · 2
P01$1,010,336 · 1
R21$466,125 · 1
R13$7,000 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Tumor”

Research focus

TumorMalignant NeoplasmsPhenotypeRadiationRadiation TherapyCellsAffectCarcinogenesisBiologyTransplantationResponseLinkMalignant Breast NeoplasmBiologicalMammary GlandRadiation ResponseMammary EpitheliumExhibitsTissuesTransforming Growth Factor BetaIonizing RadiationMediatingChimera OrganismPublishing

Grant awards (46)

Systematic Testing of a TGFβ Targeted Theranostic in Preclinical Cancer$676,567
R01 · FY2025 · CA · contact PI
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation$481,066
R01 · FY2025 · CA · contact PI
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation$163,393
R01 · FY2025 · CA · contact PI
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation$484,830
R01 · FY2024 · CA · contact PI
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation$85,223
R01 · FY2024 · CA · contact PI
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy$575,119
R01 · FY2023 · NS · contact PI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas$497,964
R01 · FY2023 · CA · contact PI
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation$497,352
R01 · FY2023 · CA · contact PI
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy$575,374
R01 · FY2022 · NS · contact PI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas$494,120
R01 · FY2022 · CA · contact PI
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy$599,837
R01 · FY2021 · NS · contact PI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas$497,714
R01 · FY2021 · CA · contact PI
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy$598,289
R01 · FY2020 · NS · contact PI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas$546,808
R01 · FY2020 · CA · contact PI
Contribution of development and age to breast cancer etiology$395,569
R01 · FY2020 · CA · contact PI
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy$594,636
R01 · FY2019 · NS · contact PI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas$486,710
R01 · FY2019 · CA · contact PI
Contribution of development and age to breast cancer etiology$485,895
R01 · FY2019 · CA · contact PI
Contribution of development and age to breast cancer etiology$85,208
R01 · FY2019 · CA · contact PI
Contribution of development and age to breast cancer etiology$569,421
R01 · FY2018 · CA · contact PI
Contribution of development and age to breast cancer etiology$58,563
R01 · FY2018 · CA · contact PI
Contribution of development and age to breast cancer etiology$501,556
R01 · FY2017 · CA · contact PI
Contribution of development and age to breast cancer etiology$435,778
R01 · FY2015 · CA · contact PI
Contextual Glioblastoma Screening For Efficacious Radiation Sensitizers$211,875
R21 · FY2015 · NS
Contribution of development and age to breast cancer etiology$30,244
R01 · FY2015 · CA · contact PI
Contextual Glioblastoma Screening For Efficacious Radiation Sensitizers$254,250
R21 · FY2014 · NS
Intercellular Interactions$124,024
U54 · FY2014 · CA · contact PI
Intercellular Interactions$122,748
U54 · FY2013 · CA · contact PI
Intercellular Interactions$131,945
U54 · FY2012 · CA · contact PI
Intercellular Interactions$147,952
U54 · FY2011 · CA · contact PI
Mammary Composition Modulated by Parity, Radiation, Age and Ovarian Status$216,559
P01 · FY2010 · CA · contact PI
Intercellular Interactions$155,502
U54 · FY2010 · CA · contact PI
Mammary Composition Modulated by Parity, Radiation, Age and Ovarian Status$217,836
P01 · FY2009 · CA · contact PI
IMPACT OF THE MICROENVIRONMENT ON THERAPEUTIC RESPONSE$322,144
U54 · FY2008 · CA · contact PI
Mammary Composition Modulated by Parity, Radiation, Age and Ovarian Status$212,496
P01 · FY2008 · CA · contact PI
IMPACT OF THE MICROENVIRONMENT ON THERAPEUTIC RESPONSE$349,568
U54 · FY2007 · CA · contact PI
Mammary Composition Modulated by Parity, Radiation, Age and Ovarian Status$208,445
P01 · FY2007 · CA · contact PI
TGFb Regulation of ER Receptor Positive Mammary Cells$317,280
R01 · FY2006 · AG · contact PI
IMPACT OF THE MICROENVIRONMENT ON THERAPEUTIC RESPONSE$192,196
U54 · FY2006 · CA · contact PI
Mammary Composition Modulated by Parity, Radiation, Age and Ovarian Status$155,000
P01 · FY2006 · CA · contact PI
TGFb Regulation of ER Receptor Positive Mammary Cells$324,915
R01 · FY2005 · AG
IMPACT OF THE MICROENVIRONMENT ON THERAPEUTIC RESPONSE$176,947
U54 · FY2005 · CA
TGFb Regulation of ER Receptor Positive Mammary Cells$324,915
R01 · FY2004 · AG
IMPACT OF THE MICROENVIRONMENT ON THERAPEUTIC RESPONSE$128,167
U54 · FY2004 · CA
TGFb Regulation of ER Receptor Positive Mammary Cells$324,915
R01 · FY2003 · AG
Gordon Research Conference on Mammary Gland Biology$7,000
R13 · FY2003 · CA